Table 3 Reduction of community-acquired and nosocomial RV-GE in age groups
Age | Pre-vaccination period (2002–2005) | Intermediate period (2006–2007) | Funded vaccination period (2008–2009) | Reductiona | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total numbers (% of total numbers) | Numbers per year (mean; 95% CI) | Total numbers (% of total numbers) | % of pre-vaccination | Total numbers (% of total numbers) | Numbers per year (mean; 95% CI) | Decreased by (%) | ||||||||
CA | NO | CA | NO | CA | NO | CA | NO | CA | NO | CA | NO | CA | NO | |
0–11 mos | 303 (32.9) | 57 (53.8) | 75.8 (67.7–83.8) | 14.3 (12.2–16.3) | 94 (27.9) | 19 (59.4) | 47.0 (37.3–56.7) | 9.5 (7.4–11.6) | 21 (16.3) | 1(25.0) | 10.5 (1.5–19.5) | 0.5 (-0.2–1.2) | 86.1 | 96.5 |
12–23 mos | 279 (30.4) | 21 (19.8) | 69.8 (57.8–81.8) | 5.3 (4.3–6.3) | 113 (33.5) | 9 (28.1) | 58.0 (56.6–59.4) | 4.5 (2.4–6.6) | 53 (41.1) | 2 (50.0) | 26.5 (6.4–46.6) | 1.0 (0–1) | 62.0 | 81.1 |
2–5 yrs | 234 (25.4) | 20 (18.9) | 58.5 (46.3–70.8) | 5.0 (3.8–6.2) | 106 (31.5) | 4 (12.5) | 53.0 (51.6–54.4) | 2.0 (-0.8–4.8) | 46 (35.7) | 1 (25.0) | 23.5 (11.7–35.3) | 0.5 (-0.2–1.0) | 59.8 | 90.0 |
6–10 yrs | 71 (7.7) | 5 (4.7) | 17.8 (13.9–21.6) | 1.3 (0.6–2.0) | 19 (5.6) | 0 | 9.5 (1.9–17.1) | 0 | 6 (4.6) | 0 | 3.0 (1.6–4.4) | 0 | 83.1 | 100 |
11–18 yrs | 33 (3.6) | 3 (2.8) | 8.3 (3.6–12.9) | 0.8 (0.5–1.1) | 5 (1.5) | 0 | 2.5 (1.8–3.2) | 0 | 3 (2.3) | 0 | 1.5 (0.8–2.2) | 0 | 81.9 | 100 |
All | 920 (100) | 106 (100) | 229.5 (196.7–262.3) | 26.5 (24.1–29.0) | 337 (100) | 32 (100) | 170.0 (160.7–178.6) | 16.0 (13.2–18.8) | 129 (100) | 4 (100) | 64.5 (20.8–108.2) | 2.0 (0–2.0) | 71.9 | 92.5 |